Esquire Financial Holdings (ESQ) Earnings Analysis
Esquire Financial Holdings (ESQ) has no confirmed upcoming earnings date. Last quarter (2026-07-23) it beat with EPS 1.6 USD vs 1.56 USD est (+2.6%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E 19.36.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does ESQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for ESQ. This page updates as the calendar is published.
ESQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-23 | 1.6 USD | 1.56 USD | +2.6% | Beat |
| 2026-04-23 | 1.58 USD | 1.52 USD | +3.9% | Beat |
| 2026-01-22 | 1.55 USD | 1.56 USD | -0.6% | Miss |
| 2025-10-23 | 1.47 USD | 1.47 USD | 0% | Beat |
| 2025-07-24 | 1.38 USD | 1.38 USD | 0% | Beat |
| 2025-04-24 | 1.33 USD | 1.31 USD | +1.5% | Beat |
| 2025-03-17 | 1.38 USD | n/a | n/a | n/a |
| 2024-10-24 | 1.34 USD | 1.31 USD | +2.3% | Beat |
Beat rate: 6/7 (86%) over reported quarters with consensus data.
ESQ valuation and analyst view
| Trailing P/E | 19.36 |
|---|---|
| Trailing EPS | 6.26 USD |
| Price / book | 3.31 |
| Dividend yield | 0.62% |
| Market cap | 1.04B |
| Analyst consensus | Buy (3 buy / 1 hold / 0 sell) |
| Avg price target | 120.5 USD |
Related research pages
Frequently asked questions
When is Esquire Financial Holdings (ESQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for ESQ. This page updates as the calendar is published.
Did ESQ beat earnings last quarter?
In its 2026-07-23 report, ESQ posted EPS of 1.6 USD versus a 1.56 USD estimate — a beat of 2.6%.
What is ESQ's earnings track record?
Over the last 7 reported quarters with consensus data, ESQ beat estimates 6 times (86%).
What is ESQ's current P/E ratio and EPS?
ESQ trades at a trailing P/E of 19.36 on trailing EPS of 6.259512015432488 USD.
What do analysts rate ESQ?
Analyst consensus is "Buy" across 4 ratings (1 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 120.5 USD.